Anzeige
Mehr »
Samstag, 30.05.2026 - Börsentäglich über 12.000 News
Der Markt schläft noch: Neben ACM explodiert die Lithium-Ressource um 650
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
286 Leser
Artikel bewerten:
(1)

American Screening Corporation: American Screening LLC Offers Comprehensive Choice of Urine and Saliva Drug Tests

SHREVEPORT, LA / ACCESSWIRE / November 17, 2020 / For close to 17 years, American Screening LLC has been supporting efforts to combat substance abuse and addiction by providing a vast array of drug testing products and striving to offer the best possible prices without compromising on quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading distributors of diagnostic products and essential medical supplies, making it a trusted partner to clinics, laboratories, medical practices, probation officers, staffing companies, and consumers. Over the years, American Screening LLC has been steadily expanding its inventory to include screening solutions for various conditions and substances, personal protective equipment (PPE), and everyday health products, but it has always remained firmly focused on stocking the best merchandise. A source of pride for the company is its extensive range of urine and saliva drug tests, which are the two most commonly administered varieties due to being the most accurate and least invasive.

"The opioid crisis in the United States has brought the problem of substance abuse into the limelight, uniting the nation in a fight against drug misuse. Apart from the heavy personal toll, alcohol and drug abuse (nicotine included) costs the US economy dearly: according to the Surgeon General, it cuts the national GDP by more than $740 billion annually through crime, lost work productivity, and health care," American Screening LLC notes. "Reducing drug misuse and addiction requires a combination of robust preventive programs, increased public awareness, strong oversight of the prescription medicines market, and extensive screening in all settings. Our company is a vital player in the last area, ensuring that accurate and affordable tests are readily available to any interested party."

American Screening LLC offers more than 80 products in the saliva testing category, covering the range from general screening for unknown substances to identifying specific drugs. Accurate, fast, and reliable, its oral fluid kits can detect the most commonly abused substances, including alcohol, amphetamines, barbiturates, cocaine, marijuana, and opiates. Many of the products are carried at reduced prices for bulk orders, which makes American Screening LLC a great partner for large clinics and medical practices. The company is also a leading supplier of urine drug tests, offering kits that enable screening at home, in work environments, and law enforcement settings. Fast and easy to use, these tests have up to 99% accuracy in detecting a long list of illicit or commonly abused substances, among them fentanyl, oxycodone, marijuana (THC), cocaine, opiates, methamphetamine, ETG, K2, amphetamines, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, tramadol, and ecstasy (MDMA). Whether looking for urine cassettes, cups, dip cards, or key cups, buyers are certain to find the right product for their needs, benefiting from attractive prices and the highest quality of customer service.

American Screening LLC is one of only a handful of companies awarded certification under the Medical Device Single Audit Program (MDSAP), which designates it as compliant with the quality management requirements of numerous jurisdictions. Established in 2004 by Ron Kilgarlin, American Screening Corporation has grown from a home-based operation into one of the leading providers of diagnostic tests and medical supplies to the United States, South America, Asia, Africa, Europe, and Australia.

American Screening, LLC: https://www.americanscreeningcorp.com/

American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/

American Screening, LLC Carries Vital Antibody Tests in Its Inventory: http://markets.ask.com/ask/news/read/40585235

Contact Information:
Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening, LLC



View source version on accesswire.com:
https://www.accesswire.com/617248/American-Screening-LLC-Offers-Comprehensive-Choice-of-Urine-and-Saliva-Drug-Tests

© 2020 ACCESS Newswire
Software vor dem Comeback – diese 5 Aktien könnten durchstarten!
Während Halbleiter- und KI-Infrastrukturwerte von einem Hoch zum nächsten jagen, wurden viele Software-Aktien in den vergangenen Monaten regelrecht aus den Depots gedrängt. Die Angst vor Disruption hat Investoren zu einem radikalen Strategiewechsel veranlasst – mit der Folge, dass zahlreiche Qualitätsunternehmen heute auf Mehrjahrestiefs notieren.

Doch genau hier entsteht eine seltene Chance. Denn während die Bewertungen im Halbleitersektor inzwischen auf ambitionierten Niveaus liegen, ist der Bewertungsabschlag bei Software-Titeln so hoch wie seit Jahren nicht mehr. Gleichzeitig liefern viele Unternehmen weiterhin starke Wachstumszahlen und integrieren KI erfolgreich in ihre Geschäftsmodelle. Die Diskrepanz zwischen Kursentwicklung und operativer Stärke könnte sich schon bald auflösen.

Für Anleger bedeutet das: antizyklisch denken und gezielt zugreifen, bevor der Markt dreht. Denn erste technische Signale deuten darauf hin, dass sich die Trendwende bereits anbahnt.

In unserem aktuellen Spezialreport stellen wir fünf Software-Aktien vor, die besonders aussichtsreich positioniert sind – mit starker Marktstellung, attraktiver Bewertung und hohem Aufholpotenzial.

Jetzt den kostenlosen Report sichern – bevor der Software-Rebound Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.